2026 and HIV Treatment and Prevention Agents

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2026

HIV Treatment and Prevention Agents

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Drug Topics

JUNE 25, 2025

1,2 “There is an extraordinary unmet need in obesity treatment, which is the ability for patients to stop GLP-1 drugs without regaining weight. 1 “These early Revita data are better than I expected and suggest the potential to prevent the weight regain we see in practice. 1 REFERENCES 1. Fractyl Health. News release. June 23, 2025.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Specialty Pharmacies Independent Pharmacies

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Pharmaceutical Companies Pharmaceutical Companies Vaccines

Pharmacy Technician Pulse

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

Stay Connected